ANNEX IISupplementary provisions
ANNEX II The Annex to Regulation (EC) No 111/2005 is amended as follows: (1) the table ‘CATEGORY 1’ is amended as follows: (a) the entry for Alpha-phenylacetoacetonitrile is replaced by the following: Substance CN designation (if different) CN Code CAS No ‘ Alpha -phenylacetoacetonitrile (APAAN) 2926 40 00 4468-48-8’ (b) in the entry for (1R,2S)-(-)-chloroephedrine, the CN code ‘2939 99 00’ is replaced by ‘2939 79 90’; (c) in the entry for (1S,2R)-(+)-chloroephedrine, the CN code ‘2939 99 00’ is replaced by ‘2939 79 90’; (d) in the entry for (1S,2S)-(+)-chloropseudoephedrine, the CN code ‘2939 99 00’ is replaced by ‘2939 79 90’; (e) in the entry for (1R,2R)-(-)-chloropseudoephedrine, the CN code ‘2939 99 00’ is replaced by ‘2939 79 90’; (f) the following entries are inserted in the appropriate place sequentially according to the CN Code: Substance CN designation (if different) CN Code CAS No ‘Methyl 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (PMK methyl glycidate) 2932 99 00 13605-48-6 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylic acid (PMK glycidic acid) 2932 99 00 2167189-50-4 Alpha -phenylacetoacetamide (APAA) 2924 29 70 4433-77-6 Methyl 2-methyl-3-phenyloxirane-2-carboxylate (BMK methyl glycidate) 2918 99 90 80532-66-7 2-methyl-3-phenyloxirane-2-carboxylic acid (BMK glycidic acid) 2918 99 90 25547-51-7 Methyl alpha -phenylacetoacetate (MAPA) 2918 30 00 16648-44-5’ (2) the table ‘Category 2’ is amended as follows: (a) in the entry for Anthranilic acid in, the CN code ‘2922 43 00’ is replaced by ‘ex 2922 43 00’; (b) the following entry is inserted in the appropriate place sequentially according to the CN Code: Substance CN designation (if different) CN Code CAS No. ‘Red phosphorus 2804 70 00 7723-14-0’ (3) in the entry for Sulphuric acid in the table ‘Category 3’, the CN code ‘2807 00 10’ is replaced by ‘2807 00 00’; (4) the table ‘Category 4’ is amended as follows: (a) in the entry for medicinal products and veterinary medicinal products containing ephedrine or its salts, the CN code ‘3003 40 20’ is replaced by ‘3003 41 00’ and the CN code ‘3004 40 20’ is replaced by ‘3004 41 00’; (b) in the entry for medicinal products and veterinary medicinal products containing pseudoephedrine or its salts, the CN code ‘3003 40 30’ is replaced by ‘3003 42 00’ and the CN code ‘3004 40 30’ is replaced by ‘3004 42 00’.